AXSOME THERAPEUTICS, INC. Fair Value Adjustment of Warrants
AXSOME THERAPEUTICS, INC. (AXSM) reported Fair Value Adjustment of Warrants of -$2.79 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2021-03-01
- AXSOME THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2018-12-31 was -$102.00K.
- AXSOME THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2018-09-30 was -$15.00K.
- AXSOME THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2018-06-30 was -$1.00K.
- AXSOME THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2018-03-31 was -$2.67M.
- AXSOME THERAPEUTICS, INC. fair value adjustment of warrants for fiscal 2018 was -$2.79M, a 532.04% decline from fiscal 2017.
- AXSOME THERAPEUTICS, INC. fair value adjustment of warrants for fiscal 2017 was $646.00K.
- AXSOME THERAPEUTICS, INC. fair value adjustment of warrants for fiscal 2015 was $108.54K, a 90.07% increase from fiscal 2014.
- AXSOME THERAPEUTICS, INC. fair value adjustment of warrants for fiscal 2014 was $57.11K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$117.00K derived: sum of 2 quarters · filed 2021-03-01 | -$118.00K derived: sum of 3 quarters · filed 2021-03-01 | -$2.79M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$15.00K 10-Q · filed 2019-11-07 | -$16.00K derived: sum of 2 quarters · filed 2019-11-07 | -$2.69M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | -$1.00K 10-Q · filed 2019-08-08 | -$2.67M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | -$2.67M 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $646.00K 10-K · filed 2020-03-12 | |||
| 2015-12-31 | $93.98K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $125.98K derived: sum of 2 quarters · filed 2018-03-07 | $109.41K derived: sum of 3 quarters · filed 2018-03-07 | $108.54K 10-K · filed 2018-03-07 |
| 2015-09-30 | $32.01K 10-Q · filed 2016-11-14 | $15.43K derived: sum of 2 quarters · filed 2016-11-14 | $14.56K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | -$16.57K 10-Q · filed 2016-08-09 | -$17.44K 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | -$870.00 10-Q/A · filed 2016-08-09 | |||
| 2014-12-31 | $57.11K 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |